NSE IPO Opens September 17: Price Band, Risks and How to Apply

An IPO from the exchange that most of India's own trading already runs through is a rare event — NSE has been the subject of listing speculation for the better part of a decade, delayed for years by a regulatory dispute that has only now been fully closed. That history is worth knowing before the numbers, because it explains why this issue looks the way it does: smaller than first expected, entirely secondary shares, and priced at a discount to its closest listed peer rather than a premium.

The IPO mechanics, in full

Every figure below is drawn from the confirmed Red Herring Prospectus filing and cross-checked across multiple financial outlets reporting the same numbers.

Allocation is split roughly 50% to qualified institutional buyers, 35% to retail investors and 15% to non-institutional investors, with a further ₹70 crore reserved for eligible NSE employees at a ₹170-per-share discount to the final price. One detail that surprises people who don't follow this closely: NSE cannot list on its own exchange. As a Market Infrastructure Institution, SEBI requires it to list on a different exchange to avoid an obvious conflict of interest — which is why, despite being NSE's own IPO, the shares will list on the BSE.

Why the issue got smaller

Earlier filings and reporting through mid-2026 pointed to an issue north of ₹30,000 crore, built around roughly 6% of NSE's equity changing hands at an estimated ₹2,000–2,100 band. The confirmed RHP tells a smaller story. Several selling shareholders trimmed how many shares they're offering before the final filing:

Between them, these cuts brought the total stake being sold down from an originally planned ~6% to about 5.1%, and the price band itself came in below the earlier ₹2,000–2,100 estimate. Worth noting: LIC, which holds a 10.72% stake in NSE, is not selling any shares in this round. A smaller, cheaper issue than first expected isn't automatically bad news for applicants — it can equally read as sellers being more disciplined about price rather than maximising the amount raised, but it's exactly the kind of change a headline figure from six months ago won't tell you.

What NSE actually earns money from

NSE's FY26 (year ended March 2026) consolidated total income came in at ₹18,713 crore, down 2% from ₹19,177 crore the year before, with consolidated profit after tax of ₹10,302 crore — down 15% year-on-year from ₹12,188 crore. EPS worked out to ₹41.62, and the board recommended a ₹35-per-share dividend, including a ₹10 special one-time payout.

The business itself is heavily concentrated in one place: transaction charges make up roughly 78.6% of FY26 revenue, and within that, trading in equity options alone accounted for about 60% of total revenue. NSE is debt-free, runs a 66.85% operating EBITDA margin, and sits on a treasury book of roughly ₹64,771 crore — a genuinely strong balance sheet. But that heavy tilt toward options-trading fees is also the single biggest thing to understand about the risk in this stock, covered below.

NSE vs BSE — the natural comparison

BSE is India's other listed stock exchange, and the only real like-for-like comparison available to investors weighing this IPO.

On earnings alone, NSE is many times BSE's size. On valuation, NSE at the top of its price band works out to roughly 43 times FY26 earnings, which is actually a discount to where BSE itself has traded — not a premium. That's a reasonable thing to know before you see "India's biggest exchange IPO" headlines and assume it must be priced aggressively; on this particular yardstick, it isn't.

The co-location case — resolved, not hanging over the IPO

For years, NSE's listing plans were held up by a SEBI investigation into preferential access some brokers allegedly got to NSE's trading servers — the "co-location" case — along with a related dark fibre matter. That's now closed. NSE settled both for a combined ₹1,491.21 crore (₹1,223.56 crore for co-location, ₹267.65 crore for dark fibre), paying an incremental ₹714.74 crore after an earlier ₹776.47 crore deposit was adjusted against the total. SEBI gave in-principle approval to the settlement on 30 July 2026, and the Supreme Court formally disposed of the case on 3 September 2026 — without NSE admitting wrongdoing. A separate antitrust case at the Competition Commission of India was also dismissed by the Supreme Court in May 2026, upholding an earlier NCLAT clearance. Both legal overhangs that delayed this IPO for years are now closed ahead of the issue opening, not open risks an applicant needs to price in.

The risk that actually matters going forward

The resolved legal cases aren't the risk to focus on — the revenue mix is. NSE's options-trading market share has been sliding: from 96.86% in FY24 to 74.7% in FY26, and roughly 68.5% in the first quarter of FY27, as SEBI has tightened rules around weekly options expiries to curb retail speculation. Since options trading drives the majority of NSE's revenue, further regulatory tightening on F&O trading — which SEBI has shown a clear appetite for over the past two years — is the single biggest swing factor for NSE's future earnings, more than any one-off legal settlement. There's also a concentration point worth knowing: the top 10 trading members account for roughly 47% of NSE's most recent quarterly revenue, meaning a meaningful slice of the business depends on a small number of large trading firms staying active.

How to actually apply

Applying follows the standard IPO process available on any SEBI-registered broker app (Zerodha, Groww, Upstox, and most full-service brokers all carry a dedicated NSE IPO listing). Open the IPO section in your broker app, select NSE, choose your lot count (in multiples of 8 shares) and bid price — either a specific price within the ₹1,700–1,785 band or "cut-off," which bids at the final price — and submit. This triggers a UPI mandate request to your UPI app, which you need to approve before the broker's daily cutoff (usually the same day). Your funds are blocked, not debited, until allotment on 22 September; if you aren't allotted shares, the block is released automatically.

About that GMP number you'll see everywhere

The honest bottom line

This is a large, financially strong, debt-free business with a genuinely rare listing story — but it's a pure secondary sale (none of your money goes to NSE), priced at a discount to its closest peer on a P/E basis, carrying real regulatory exposure to future F&O rule changes, and coming to market with a GMP that has already proven volatile. None of that makes it automatically a good or bad application — it's context that the "India's biggest IPO" headlines this week generally won't spell out. This article is general information, not investment advice; whether and how much to apply for is a decision to make against your own portfolio and risk tolerance, not a GMP quote or a headline.

Frequently asked questions